Showing results (431-440 of 554) with videos related to

Sort By:
Pageof 56
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2026
Evolution of AR and non-AR alterations in circulating tumor DNA of metastatic prostate cancer patients treated in the phase 3 Alliance A031201 trialJosé C Valentín López, Chenxi Yu, Todd P Knutson, et al.
Prostate Cancer and Prostatic Diseases|January 21, 2015
Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxelH H Cheng, R Gulati, A Azad, et al.
NPJ Genomic Medicine|January 22, 2024
Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancerHannah E Bergom, Laura A Sena, Abderrahman Day, et al.
European Journal of Cancer (Oxford, England : 1990)|April 24, 2021
Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancerH I Scher, A J Armstrong, J D Schonhoft, et al.
European Urology|August 7, 2025
Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate CancerSusan Halabi, Siyuan Guo, Bin Luo, et al.
Journal for Immunotherapy of Cancer|July 1, 2021
TGM4: an immunogenic prostate-restricted antigenZoila A Lopez-Bujanda, Aleksandar Obradovic, Thomas R Nirschl, et al.
JCI Insight|November 16, 2023
MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progressionJiayu Chen, Qizhi Zheng, Jessica L Hicks, et al.
Cancer Cell|November 22, 2024
Mutation burden and anti-PD-1 outcomes are not universally associated with immune cell infiltration or lymphoid activationDavid Hsiehchen, Andrew Elliott, Joanne Xiu, et al.
JCO Precision Oncology|September 28, 2023
Pan-Cancer Analysis of Copy-Number Features Identifies Recurrent Signatures and a Homologous Recombination Deficiency Biomarker to Predict Poly (ADP-Ribose) Polymerase Inhibitor ResponseJay A Moore, Kuei-Ting Chen, Russell Madison, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progressionJiayu Chen, Qizhi Zheng, Jessica L Hicks, et al.
Pageof 56